K
Klaus Pantel
Researcher at University of Hamburg
Publications - 566
Citations - 36666
Klaus Pantel is an academic researcher from University of Hamburg. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 90, co-authored 486 publications receiving 29848 citations.
Papers
More filters
Journal ArticleDOI
Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients.
Andra Kuske,Tobias M. Gorges,Pierre Tennstedt,Anne-Kathrin Tiebel,Raisa S. Pompe,Felix Preißer,Sandra Prues,Martine Mazel,Athina Markou,Evi Lianidou,Sven Peine,Catherine Alix-Panabières,Sabine Riethdorf,Burkhard Beyer,Thorsten Schlomm,Klaus Pantel +15 more
TL;DR: CTC-based liquid biopsies have the potential to monitor MRD in patients with non-metastatic prostate cancer by combining three independent CTC assays: the CellSearch system, an in vivo CellCollector and the EPISPOT.
Journal ArticleDOI
Tumor cell dormancy: an NCI workshop report.
TL;DR: This report summarizes the key outcomes of this workshop, which reviewed studies of hematological tumor cell dormancy and how this insight could best be applied to the solid tumors.
Journal ArticleDOI
Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer.
Wulf Sienel,Joe Hellers,Alicia Morresi-Hauf,Ralf Lichtinghagen,Wolf Mutschler,Marianne Jochum,Christoph Klein,Bernward Passlick,Klaus Pantel +8 more
TL;DR: Investigation of immunohistochemical evaluation of MMP‐9 expression may provide a basis for the preselection of patients to be included in trials investigating specific protease inhibitor therapy after surgical resection of NSCLC.
Journal ArticleDOI
Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion
Michaela Wrage,Salla Ruosaari,Paul P. Eijk,Jussuf T. Kaifi,Jaakko Hollmén,Emre F. Yekebas,Jakob R. Izbicki,Ruud H. Brakenhoff,Thomas Streichert,Sabine Riethdorf,Markus Glatzel,Bauke Ylstra,Klaus Pantel,Harriet Wikman +13 more
TL;DR: The data indicate, for the first time, that early hematogenous dissemination of tumor cells might be driven by a specific pattern of genomic changes.
Journal ArticleDOI
Circulating DNA as biomarker in breast cancer
Heidi Schwarzenbach,Klaus Pantel +1 more
TL;DR: The present review discussed technical aspects and clinical relevance of the analyses of circulating plasma/serum DNA in patients with breast cancer.